Stockscreener 앱 받기
3.415
0.44%
0.015
전일 마감가:
$3.40
열려 있는:
$3.35
하루 거래량:
375.91K
Relative Volume:
0.20
시가총액:
$588.78M
수익:
$25.55M
순이익/손실:
$-341.97M
주가수익비율:
-1.2196
EPS:
-2.8
순현금흐름:
$-304.44M
1주 성능:
+0.74%
1개월 성능:
-5.92%
6개월 성능:
-12.88%
1년 성능:
-53.98%
1일 변동 폭
$3.31
$3.42
1주일 범위
$3.31
$3.65
52주 변동 폭
$1.775
$10.72
릴레이 테라퓨틱스 Stock (RLAY) Company Profile
명칭
Relay Therapeutics Inc
전화
617-370-8837
주소
60 HAMPSHIRE STREET, CAMBRIDGE
RLAY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
3.415 | 598.27M | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.20 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
602.03 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
667.03 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
310.45 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
릴레이 테라퓨틱스 Stock (RLAY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-17 | 개시 | Wells Fargo | Equal Weight |
| 2024-09-10 | 재개 | Goldman | Buy |
| 2024-09-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-04-20 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-04-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 개시 | Raymond James | Outperform |
| 2023-02-03 | 개시 | Oppenheimer | Outperform |
| 2022-09-30 | 개시 | Barclays | Equal Weight |
| 2022-09-02 | 개시 | Stifel | Buy |
| 2022-06-06 | 개시 | Jefferies | Underperform |
| 2022-02-01 | 개시 | Berenberg | Buy |
| 2021-07-21 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-08 | 개시 | JMP Securities | Mkt Outperform |
| 2020-11-05 | 개시 | H.C. Wainwright | Buy |
| 2020-08-10 | 개시 | Cowen | Outperform |
| 2020-08-10 | 개시 | Goldman | Buy |
| 2020-08-10 | 개시 | Guggenheim | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
모두보기
릴레이 테라퓨틱스 주식(RLAY)의 최신 뉴스
Relay Therapeutics shares fall 2.45% intraday as Piper Sandler initiates coverage on Bicara Therapeutics. - AInvest
Raymond James Lowers Relay Therapeutics (RLAY) PT to $19 Following Q2 Results, Strategic Cost Cuts - Yahoo Finance
Published on: 2025-08-15 19:49:23 - beatles.ru
Relay Therapeutics Soars 13.57% on Earnings Beat - AInvest
Moving Average Crossover Confirms Uptrend in Relay Therapeutics Inc.July 2025 Intraday Action & Weekly Return Optimization Alerts - metal.it
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates - ADVFN Brasil
Relay Therapeutics’ SWOT analysis: AI-driven biotech’s stock faces pivotal phase - Investing.com India
Relay Therapeutics (RLAY) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Analysts’ Opinions Are Mixed on These Healthcare Stocks: 89bio (ETNB), Relay Therapeutics (RLAY) and Ironwood Pharma (IRWD) - The Globe and Mail
Relay Therapeutics (RLAY) Receives Buy Rating from Leerink Partners with $12.00 Price Target - AInvest
Relay Therapeutics Reports Q2 2025 Financial Results and Progress - TipRanks
Raymond James Keeps 'Strong Buy' Rating on Relay Therapeutics but Lowers Price Target to $19 - AInvest
Will Relay Therapeutics Inc. continue its uptrendReal Time Growth Signal with Smart Setup - Newser
A Quick Look at Today's Ratings for Relay Therapeutics(RLAY.US), With a Forecast Between $17 to $19 - 富途牛牛
Why Relay Therapeutics Inc. stock attracts strong analyst attentionGrowth Watchlist for Long Term Positioning - Newser
Screener Results Flag Relay Therapeutics Inc. as OversoldReal-Time Market Sentiment Tracking Gains Momentum - beatles.ru
Relay Therapeutics (NASDAQ:RLAY) Shares Gap Down After Analyst Downgrade - Defense World
Relay Therapeutics: Raymond James Maintains Strong Buy, PT Down to $19. - AInvest
RLAY.O Drops 11.7%: Uncovering the Forces Behind the Sudden Move - AInvest
A Quick Look at Today's Ratings for Relay Therapeutics(RLAY.US), With a Forecast Between $4 to $17 - 富途牛牛
Wells Fargo reiterates Equal Weight rating on Relay Therapeutics stock By Investing.com - Investing.com Canada
Relay Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Relay Therapeutics reports Q2 EPS (41c), consensus (47c) - TipRanks
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Evaluating Relay Therapeutics' Momentum: Strategic Execution and Pipeline Progress in Q2 2025 - AInvest
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates | RLAY Stock News - GuruFocus
Barclays Reiterates a Buy Rating on Relay Therapeutics (RLAY) - MSN
What’s the recovery path for long term holders of Relay Therapeutics Inc.Free Capital Preserving Trade Plan Templates - Newser
Relay Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowMomentum Screener with Buy and Sell Areas - Newser
Relay Therapeutics Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
Barclays Maintains a Buy Rating on Relay Therapeutics (RLAY), Sets a $17 PT - MSN
Relay Therapeutics (RLAY) Expected to Announce Earnings on Thursday - Defense World
We're Keeping An Eye On Relay Therapeutics' (NASDAQ:RLAY) Cash Burn Rate - 富途牛牛
What makes Relay Therapeutics Inc. stock price move sharplyUnprecedented profits - Jammu Links News
10 Best Strong Buy Penny Stocks to Buy Now - Insider Monkey
How does Relay Therapeutics Inc. generate profit in a changing economyOutstanding stock performance - Jammu Links News
Should I hold or sell Relay Therapeutics Inc. stock in 2025Build a winning investment strategy today - Jammu Links News
Is Relay Therapeutics Inc. a good long term investmentDynamic profit opportunities - jammulinksnews.com
What are the latest earnings results for Relay Therapeutics Inc.Unlock exclusive stock market insights - Jammu Links News
Why is Relay Therapeutics Inc. stock attracting strong analyst attentionStay ahead with daily expert stock picks - Jammu Links News
Critical Survey: SHINECO (NASDAQ:SISI) vs. Relay Therapeutics (NASDAQ:RLAY) - Defense World
What catalysts could drive Relay Therapeutics Inc. stock higher in 2025Discover stocks with superior performance - Jammu Links News
What drives Relay Therapeutics Inc. stock priceMaximize portfolio growth with professional advice - Jammu Links News
How does Relay Therapeutics Inc. compare to its industry peersGet alerts on high-potential market moves - Jammu Links News
Relay Therapeutics (RLAY): Is H2 2025 the Inflection Point for AI-Driven Drug Discovery? - AInvest
Relay Therapeutics: What's Next For H2 2025? - Seeking Alpha
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025 - 富途牛牛
Relay Therapeutics Q2 2025 Financial Results and Corporate Highlights Announced for August 7, 2025 - AInvest
Relay Therapeutics’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment - TipRanks
릴레이 테라퓨틱스 (RLAY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
릴레이 테라퓨틱스 주식 (RLAY) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Rahmer Peter | See remarks |
Jul 28 '25 |
Sale |
3.74 |
1,359 |
5,083 |
393,722 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 29 '25 |
Sale |
3.68 |
18,380 |
67,638 |
335,295 |
| Catinazzo Thomas | Chief Financial Officer |
Jul 28 '25 |
Sale |
3.74 |
1,701 |
6,362 |
353,675 |
| Bergstrom Donald A | President, R&D |
Jul 29 '25 |
Sale |
3.68 |
26,701 |
98,260 |
552,720 |
| Bergstrom Donald A | President, R&D |
Jul 28 '25 |
Sale |
3.74 |
4,069 |
15,218 |
579,421 |
| Adams Brian | Chief Legal Officer |
Jul 29 '25 |
Sale |
3.68 |
18,276 |
67,256 |
371,472 |
| Adams Brian | Chief Legal Officer |
Jul 28 '25 |
Sale |
3.74 |
1,637 |
6,122 |
389,748 |
| Patel Sanjiv | President and CEO |
Jul 09 '25 |
Sale |
3.57 |
61,379 |
219,123 |
765,288 |
| Rahmer Peter | See remarks |
Apr 30 '25 |
Sale |
3.00 |
10,739 |
32,217 |
390,081 |
| Rahmer Peter | See remarks |
Apr 28 '25 |
Sale |
3.17 |
1,364 |
4,324 |
400,820 |
1.08%
0.57%
자본화:
|
볼륨(24시간):